RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE.
KPV (lysine-proline-valine) is a tripeptide fragment derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone. Laboratory research has examined its interaction with inflammatory signaling pathways.
Research background: Kannengiesser et al. evaluated KPV in two murine models of colitis and reported anti-inflammatory activity in those animal models. This was preclinical mouse research, not a human clinical trial, and it did not evaluate any Amino Fusion Labs material.
Primary study: Kannengiesser K, et al. “Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.” Inflammatory Bowel Diseases (2008).
https://pubmed.ncbi.nlm.nih.gov/18092346/
This citation is provided solely as scientific background. Animal-model findings cannot establish human safety or effectiveness and do not establish the identity, purity, quality, safety, effectiveness, FDA approval, or suitability of this product.
This product has not been evaluated or approved by the U.S. Food and Drug Administration. It is not intended for ingestion, injection, inhalation, topical application, compounding, diagnostic use, therapeutic use, or any other administration to humans or animals. Amino Fusion Labs provides no medical advice, dosing guidance, reconstitution instructions, or administration instructions.
SUPPLIED AS LYOPHILIZED POWDER. For qualified laboratory research only. Any preparation or handling must follow an authorized laboratory’s validated protocol. Not for human or veterinary use. No dosing, reconstitution, compounding, or administration instructions are provided.
RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE.
KPV (lysine-proline-valine) is a tripeptide fragment derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone. Laboratory research has examined its interaction with inflammatory signaling pathways.
Research background: Kannengiesser et al. evaluated KPV in two murine models of colitis and reported anti-inflammatory activity in those animal models. This was preclinical mouse research, not a human clinical trial, and it did not evaluate any Amino Fusion Labs material.
Primary study: Kannengiesser K, et al. “Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.” Inflammatory Bowel Diseases (2008).
https://pubmed.ncbi.nlm.nih.gov/18092346/
This citation is provided solely as scientific background. Animal-model findings cannot establish human safety or effectiveness and do not establish the identity, purity, quality, safety, effectiveness, FDA approval, or suitability of this product.
This product has not been evaluated or approved by the U.S. Food and Drug Administration. It is not intended for ingestion, injection, inhalation, topical application, compounding, diagnostic use, therapeutic use, or any other administration to humans or animals. Amino Fusion Labs provides no medical advice, dosing guidance, reconstitution instructions, or administration instructions.
SUPPLIED AS LYOPHILIZED POWDER. For qualified laboratory research only. Any preparation or handling must follow an authorized laboratory’s validated protocol. Not for human or veterinary use. No dosing, reconstitution, compounding, or administration instructions are provided.
